Back to top

DexCom (DXCM)

(Delayed Data from NSDQ)

$571.01 USD


-20.95 (-3.54%)

Updated Nov 29, 2021 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.42%
5Strong Sell3.08%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 26% (188 out of 253)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Company Summary

San Diego, CA-based DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients.

A key element of DexCom’s monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company’s monitoring systems aim to provide real-time continuous blood glucose values, trend data ...

General Information

DexCom, Inc.



Phone: 858-200-0200

Fax: 858-200-0201



Industry Medical - Instruments
Sector Medical
Fiscal Year End December
Last Reported Quarter 9/30/2021
Next EPS Date 2/10/2022

EPS Information

Current Quarter EPS Consensus Estimate 0.85
Current Year EPS Consensus Estimate 2.79
Estimated Long-Term EPS Growth Rate NA
Next EPS Report Date 2/10/2022

Price and Volume Information

Zacks Rank Premium
Yesterday's Close 591.96
52 Week High 659.45
52 Week Low 313.38
Beta 0.73
20 Day Moving Average 564,523.50
Target Price Consensus 572.76


% Price Change
4 Week -5.01
12 Week 9.13
YTD 60.11
% Price Change Relative to S&P 500
4 Week -4.79
12 Week 7.73
YTD 30.89
Share Information
Shares Outstanding (millions) 96.92
Market Capitalization (millions) 57,373.97
Short Ratio NA
Last Split Date NA
Dividend Information
Dividend Yield 0.00%
Annual Dividend $0.00
Payout Ratio 0.00
Change in Payout Ratio 0.00
Last Dividend Payout / Amount NA / $0.00

Fundamental Ratios

P/E (F1) 212.51
Trailing 12 Months 204.83
PEG Ratio NA
EPS Growth
vs. Previous Year -5.32%
vs. Previous Quarter 17.11%
Sales Growth
vs. Previous Year 29.81%
vs. Previous Quarter 9.26%
Price Ratios
Price/Book 26.86
Price/Cash Flow 153.80
Price / Sales 24.74
9/30/21 14.65
6/30/21 16.17
3/31/21 17.86
9/30/21 6.42
6/30/21 6.87
3/31/21 7.33
Current Ratio
9/30/21 4.98
6/30/21 5.78
3/31/21 5.70
Quick Ratio
9/30/21 4.50
6/30/21 5.25
3/31/21 5.22
Operating Margin
9/30/21 12.42
6/30/21 13.47
3/31/21 14.50
Net Margin
9/30/21 22.82
6/30/21 24.45
3/31/21 25.36
Pre-Tax Margin
9/30/21 11.64
6/30/21 11.72
3/31/21 11.04
Book Value
9/30/21 22.04
6/30/21 20.65
3/31/21 19.68
Inventory Turnover
9/30/21 2.38
6/30/21 2.56
3/31/21 2.96
9/30/21 0.80
6/30/21 0.86
3/31/21 0.89
Debt to Capital
9/30/21 44.37
6/30/21 46.13
3/31/21 47.02